M
Michael R. Folkert
Researcher at University of Texas Southwestern Medical Center
Publications - 124
Citations - 1943
Michael R. Folkert is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Brachytherapy & Radiation therapy. The author has an hindex of 21, co-authored 117 publications receiving 1492 citations. Previous affiliations of Michael R. Folkert include Harvard University & Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal ArticleDOI
GPU-based streaming architectures for fast cone-beam CT image reconstruction and demons deformable registration.
TL;DR: This paper shows how to significantly accelerate cone-beam CT reconstruction and 3D deformable image registration using the stream-processing model, and describes data-parallel designs for the Feldkamp, Davis and Kress reconstruction algorithm, and the demons deformable registration algorithm, suitable for use on a commodity graphics processing unit.
Journal ArticleDOI
Outcomes and Toxicity for Hypofractionated and Single-Fraction Image-Guided Stereotactic Radiosurgery for Sarcomas Metastasizing to the Spine
Michael R. Folkert,Mark H. Bilsky,Ashlyn Tom,Jung Hun Oh,Kaled M. Alektiar,Ilya Laufer,William D. Tap,Yoshiya Yamada +7 more
TL;DR: In the largest series of metastatic sarcoma to the spine to date, IG-SRS provides excellent LC in the setting of an aggressive disease with low radiation sensitivity and poor prognosis.
Journal ArticleDOI
Comparison of Local Recurrence With Conventional and Intensity-Modulated Radiation Therapy for Primary Soft-Tissue Sarcomas of the Extremity
Michael R. Folkert,Samuel Singer,Murray F. Brennan,Deborah Kuk,Li-Xuan Qin,Wendy K. Kobayashi,Aimee M. Crago,Kaled M. Alektiar +7 more
TL;DR: Despite a preponderance of higher-risk features in the IMRT group, IMRT was associated with significantly reduced local recurrence compared with conventional EBRT for primary STS of the extremity.
Journal ArticleDOI
Dose to the Bladder Neck Is the Most Important Predictor for Acute and Late Toxicity After Low-Dose-Rate Prostate Brachytherapy: Implications for Establishing New Dose Constraints for Treatment Planning
Lara Hathout,Michael R. Folkert,Marisa A. Kollmeier,Yoshiya Yamada,Gil'ad N. Cohen,Michael J. Zelefsky +5 more
TL;DR: Bladder neck D2cc >50% was the strongest predictor for grade ≥2 AUT and LUT in patients treated with low-dose-rate brachytherapy with or without external beam radiation therapy (EBRT) and these data support inclusion of bladder neck constraints into brachyTherapy planning to decrease urinary toxicity.
Journal ArticleDOI
Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT)
TL;DR: This review will discuss the justification for and techniques used to deliver ablative doses to improve treatment outcomes, interactions with biological and immunologic therapy, and special procedures to spare normal tissue, which have facilitated the expanding role for these techniques in the management of a wide range of malignant histologies and disease states.